株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオバンキングの世界市場予測 2022年:血液製剤・ヒト組織・細胞株・核酸

Biobanking Market by Product and Service(Equipment, Consumables, Services, Software), Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids), Application( Regenerative Medicine, Life Science, Clinical Research) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 541445
出版日 ページ情報 英文 173 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.97円で換算しております。
Back to Top
バイオバンキングの世界市場予測 2022年:血液製剤・ヒト組織・細胞株・核酸 Biobanking Market by Product and Service(Equipment, Consumables, Services, Software), Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids), Application( Regenerative Medicine, Life Science, Clinical Research) - Global Forecast to 2022
出版日: 2017年08月02日 ページ情報: 英文 173 Pages
概要

バイオバンキングの市場規模は、2017年の18億5,000万米ドルから、2022年までに26億9,000万米ドルへ達すると見られ、7.8%のCAGR (年間複合成長率) が見込まれています。同市場の成長を促進する要因は、疾病研究のためのゲノミクス研究活動数の増加、バイオバンキングの進歩と新生児の臍帯血幹細胞を保存する動向の拡大、再生医療研究を支援する政府 & 民間資金、およびコスト効果的な創薬・開発のニーズの高まりなどの要因に促進されています。一方、高額な自動化コストおよび生体試料サンプルの調達に関連した課題によって、同市場の成長はある程度抑制されています。

当レポートでは、バイオバンキングの世界市場に注目し、主要企業の製品ポートフォリオに関する包括的な情報、最新技術、R&D活動、および製品発売に関する詳細な考察、市場戦略、地域 & 事業区分、および製品ポートフォリオの詳細な評価、新興市場についての包括的な情報、新製品・未開発地域・近年の発展動向・投資に関する情報などをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • バイオバンキング:市場概要
  • 地域分析:バイオバンキング市場、地域 & サンプルタイプ別
  • バイオバンキング市場:製品・サービス別
  • バイオバンキング市場の地域概要

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 成長促進要因
    • 成長抑制要因
    • 機会
    • 課題

第6章 世界のバイオバンキング市場:製品・サービス別

  • イントロダクション
  • 装置
  • 消耗品
  • サービス
  • ソフトウェア

第7章 世界のバイオバンキング市場:サンプルタイプ別

  • イントロダクション
  • 血液製剤
  • ヒト組織
  • 細胞株
  • 核酸
  • 体液
  • 排泄物製品

第8章 世界のバイオバンキング市場:ストレージタイプ別

  • イントロダクション
  • マニュアルストレージ
  • 自動ストレージ

第9章 世界のバイオバンキング市場:アプリケーション別

  • イントロダクション
  • 再生医療
  • ライフサイエンス研究
  • 臨床研究

第10章 世界のバイオバンキング市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋 (APAC)
  • その他

第11章 競合情勢

  • イントロダクション
  • 市場シェア分析
  • 競合リーダーシップマッピング
  • 競合ベンチマーキング

第12章 企業プロファイル

  • THERMO FISHER SCIENTIFIC INC.
  • パナソニック ヘルスケアホールディングス
  • BECTON, DICKINSON AND COMPANY
  • QIAGEN N.V.
  • MERCK KGAA
  • VWR CORPORATION
  • TECAN TRADING AG
  • BROOKS AUTOMATION, INC.
  • CHART INDUSTRIES, INC.
  • HAMILTON COMPANY
  • GREINER HOLDING AG
  • PROMEGA CORPORATION

第13章 付録

図表リスト

目次
Product Code: BT 1224

The biobanking market is expected to reach USD 2.69 billion by 2022 from USD 1.85 billion in 2017, at a CAGR of 7.8%. Factors driving the growth of this market include the increasing number of genomics research activities for studying diseases; advances in biobanking and the growing trend of conserving cord blood stem cells of newborns; government & private funding to support regenerative medicine research, and the growing need for cost-effective drug discovery and development. On the other hand, the growth of this market is hindered to some extent due to the high cost of automation and issues related to biospecimen sample procurement.

"Automated storage is expected to register the highest CAGR during the forecast period"

The biobanking market is classified by storage type into manual and automated storage. The automated storage type segment is expected to grow at a higher rate during the forecast period. This is attributed to launch of new and advanced automated storage equipment and increasing demand for the quality storage of samples.

"Regenerative medicine to dominate the market during the forecast period"

The biobanking market is segmented based on applications regenerative medicine, life science research, and clinical research. In 2017, the regenerative medicine segment is expected to command the largest share and is also estimated to grow at the fastest rate as compared to other segments. This can be attributed to increasing research activities in the field of regenerative medicine and rising demand for well-annotated and quality biosamples for research.

"Asia-Pacific is estimated to grow at the highest CAGR during the forecast period"

Geographically, the biobanking market is dominated by North America, followed by Europe. The Asia-Pacific region is estimated to grow at the fastest rate which can be attributed to the large population in China and India, increasing research in regenerative medicine, and improving life sciences research infrastructure in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 70% and Tier 2 - 30%
  • By Designation - C level - 62%, Director level - 21%, Others - 17%
  • By Region - North America - 50%, Europe - 20%, Asia- Pacific - 30%

The key players in the biobanking market include Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), Brooks Automation (U.S.), TTP Labtech Ltd (U.K.), VWR Corporation (U.S.), Promega Corporation (U.S.), Worthington Industries [(Taylor Wharton, U.S.)], Chart Industries (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Micronic (Netherlands), LVL Technologies GmbH & Co. KG (Germany), Panasonic Healthcare Holdings Co. Ltd (Japan), Greiner Bio One [Greiner Holding AG, Austria)], Biokryo GmbH (Germany), Biobank AS (Norway), Biorep Technologies Inc. (U.S.), Cell & Co Bioservices (France), RUCDR infinite biologics (U.S.), Modul-Bio (France), CSols Ltd (U.K.), Ziath (U.K.), and LabVantage Solutions Inc. (U.S.).

Study Coverage:

The report analyses the biobanking market by product and service, sample type, storage type, application and regions. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the type, products, applications, end users, and regions.

Key Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the biobanking market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the biobanking market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the biobanking market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various biobanking products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the biobanking market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
  • 1.4. YEARS CONSIDERED FOR THE STUDY
  • 1.5. CURRENCY
  • 1.6. LIMITATIONS
  • 1.7. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY DATA
  • 2.2. PRIMARY DATA
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. BIOBANKING: MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: BIOBANKING MARKET, BY REGION & SAMPLE TYPE (2017)
  • 4.3. BIOBANKING MARKET, BY PRODUCT & SERVICE, 2017-2022
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE BIOBANKING MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing number of genomics research activities for studying diseases
      • 5.2.1.2. Advances in biobanking and growing trend of conserving cord blood stem cells of newborns
      • 5.2.1.3. Government & private funding to support regenerative medicine research
      • 5.2.1.4. Growing need for cost-effective drug discovery and development 36 
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of automation
      • 5.2.2.2. Issues related to biospecimen sample procurement
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging countries
      • 5.2.3.2. Growing focus on the research and development of cell therapies
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Long-term sustainability of biobanks

6. GLOBAL BIOBANKING MARKET, BY PRODUCT AND SERVICE

  • 6.1. INTRODUCTION
  • 6.2. EQUIPMENT
    • 6.2.1. STORAGE EQUIPMENT
    • 6.2.2. SAMPLE ANALYSIS EQUIPMENT
    • 6.2.3. SAMPLE PROCESSING EQUIPMENT
    • 6.2.4. SAMPLE TRANSPORT EQUIPMENT
  • 6.3. CONSUMABLES
    • 6.3.1. STORAGE CONSUMABLES
    • 6.3.2. ANALYSIS CONSUMABLES
    • 6.3.3. PROCESSING CONSUMABLES
    • 6.3.4. COLLECTION CONSUMABLES
  • 6.4. SERVICES
    • 6.4.1. STORAGE SERVICES
    • 6.4.2. PROCESSING SERVICES
    • 6.4.3. TRANSPORT SERVICES
    • 6.4.4. SUPPLY SERVICES
  • 6.5. SOFTWARE

7. GLOBAL BIOBANKING MARKET, BY SAMPLE TYPE

  • 7.1. INTRODUCTION
  • 7.2. BLOOD PRODUCTS
  • 7.3. HUMAN TISSUES
  • 7.4. CELL LINES
  • 7.5. NUCLEIC ACIDS
  • 7.6. BIOLOGICAL FLUIDS
  • 7.7. HUMAN WASTE PRODUCTS

8. GLOBAL BIOBANKING MARKET, BY STORAGE TYPE

  • 8.1. INTRODUCTION
  • 8.2. MANUAL STORAGE
  • 8.3. AUTOMATED STORAGE 63 

9. GLOBAL BIOBANKING MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. REGENERATIVE MEDICINE
  • 9.3. LIFE SCIENCE RESEARCH
  • 9.4. CLINICAL RESEARCH

10. GLOBAL BIOBANKING MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. FRANCE
    • 10.3.3. U.K.
    • 10.3.4. ITALY
    • 10.3.5. NETHERLANDS
    • 10.3.6. REST OF EUROPE (ROE)
  • 10.4. ASIA-PACIFIC
    • 10.4.1. CHINA
    • 10.4.2. JAPAN
    • 10.4.3. INDIA
    • 10.4.4. SOUTH KOREA
    • 10.4.5. AUSTRALIA
    • 10.4.6. REST OF ASIA PACIFIC (ROAPAC)
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE LEADERSHIP MAPPING
    • 11.3.1. VISIONARY LEADERS
    • 11.3.2. INNOVATORS
    • 11.3.3. DYNAMIC DIFFERENTIATORS
    • 11.3.4. EMERGING COMPANIES 126 
  • 11.4. COMPETITIVE BENCHMARKING
    • 11.4.1. STRENGTH OF PRODUCT PORTFOLIO
    • 11.4.2. BUSINESS STRATEGY EXCELLENCE

Top 25 companies analyzed for this study are - Thermo Fisher Scientific Inc. (U.S.), Panasonic Healthcare Holdings Co. Ltd. (Japan), Becton, Dickinson and Company (U.S.), QIAGEN N.V. (Germany), Merck KGaA (Germany), VWR Corporation (U.S.), Tecan Group Ltd. (Switzerland), Brooks Automation, Inc. (U.S.), Chart Industries, Inc. (U.S.), Hamilton Company (U.S.), Greiner Holding AG (Austria), Promega Corporation (U.S.), Worthington Industries (U.S.), LabVantage Solutions, Inc. (U.S.), HighRes Biosolutions (U.S.), Freezerworks (U.S.), LGC Limited (U.K.), TTP Group (U.K.), Micronic (Netherlands), Custom Biogenic Systems (U.S.), Cryotherm GmbH & Co. KG (Germany), Cell & Co. Bioservices (France), LVL Technologies GmbH & Co. KG (Germany), Biokryo GmbH (Germany), and Askion GmbH (Germany).

12. COMPANY PROFILES (OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*

  • 12.1. THERMO FISHER SCIENTIFIC INC.
  • 12.2. PANASONIC HEALTHCARE HOLDINGS CO., LTD.
  • 12.3. BECTON, DICKINSON AND COMPANY
  • 12.4. QIAGEN N.V.
  • 12.5. MERCK KGAA
  • 12.6. VWR CORPORATION
  • 12.7. TECAN TRADING AG
  • 12.8. BROOKS AUTOMATION, INC.
  • 12.9. CHART INDUSTRIES, INC.
  • 12.10. HAMILTON COMPANY
  • 12.11. GREINER HOLDING AG
  • 12.13. PROMEGA CORPORATION

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INDUSTRY INSIGHTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: BIOBANKING: MARKET SNAPSHOT
  • TABLE 2: BIOBANKING MARKET, BY PRODUCT AND SERVICE, 2015-2022 (USD MILLION)
  • TABLE 3: BIOBANKING EQUIPMENT MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 5: STORAGE EQUIPMENT MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: SAMPLE ANALYSIS EQUIPMENT MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: SAMPLE PROCESSING EQUIPMENT MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: SAMPLE TRANSPORT EQUIPMENT MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: BIOBANKING CONSUMABLES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 11: STORAGE CONSUMABLES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: ANALYSIS CONSUMABLES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: PROCESSING CONSUMABLES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: COLLECTION CONSUMABLES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: BIOBANKING SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: BIOBANKING SERVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 17: STORAGE SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: PROCESSING SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: TRANSPORT SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: SUPPLY SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: BIOBANKING SOFTWARE MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 23: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: BIOBANKING MARKET FOR HUMAN TISSUES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: BIOBANKING MARKET FOR CELL LINES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 30: BIOBANKING MARKET FOR MANUAL STORAGE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 33: BIOBANKING MARKET FOR REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 34: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: BIOBANKING MARKET FOR CLINICAL RESEARCH APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 36: BIOBANKING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 37: NORTH AMERICA: BIOBANKING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 38: NORTH AMERICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 39: NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2015-2022 (USD MILLION)
  • TABLE 40: NORTH AMERICA: BIOBANKING CONSUMABLES MARKET, BY CONSUMABLES TYPE, 2015-2022 (USD MILLION)
  • TABLE 41: NORTH AMERICA: BIOBANKING SERVICES MARKET, BY SERVICES TYPE, 2015-2022 (USD MILLION)
  • TABLE 42: NORTH AMERICA: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 43: NORTH AMERICA: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 44: NORTH AMERICA: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 45: U.S.: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 46: U.S.: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: U.S.: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 48: U.S.: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 49: CANADA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 50: CANADA: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: CANADA: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: CANADA: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 53: EUROPE: BIOBANKING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 54: EUROPE: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 55: EUROPE: BIOBANKING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2015-2022 (USD MILLION)
  • TABLE 56: EUROPE: BIOBANKING CONSUMABLES MARKET, BY CONSUMABLES TYPE, 2015-2022 (USD MILLION)
  • TABLE 57: EUROPE: BIOBANKING SERVICES MARKET, BY SERVICES TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: EUROPE: BIOBANKING MARKET, BY SAMPLE TYPE 2015-2022 (USD MILLION)
  • TABLE 59: EUROPE: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 60: EUROPE: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 61: GERMANY: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 62: GERMANY: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 63: GERMANY: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: GERMANY: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 65: FRANCE: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 66: FRANCE: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: FRANCE: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: FRANCE: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 69: U.K.: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 70: U.K.: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 71: U.K.: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 72: U.K.: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 73: ITALY: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 74: ITALY: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 75: ITALY: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: ITALY: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 77: NETHERLANDS: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 78: NETHERLANDS: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 79: NETHERLANDS: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 80: NETHERLANDS: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 81: ROE: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 82: ROE: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 83: ROE: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 84: ROE: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 85: ASIA-PACIFIC: BIOBANKING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 86: ASIA-PACIFIC: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 87: ASIA-PACIFIC: BIOBANKING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2015-2022 (USD MILLION)
  • TABLE 88: ASIA-PACIFIC: BIOBANKING CONSUMABLES MARKET, BY CONSUMABLES TYPE, 2015-2022 (USD MILLION)
  • TABLE 89: ASIA-PACIFIC: BIOBANKING SERVICES MARKET, BY SERVICES TYPE, 2015-2022 (USD MILLION)
  • TABLE 90: ASIA-PACIFIC: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 91: ASIA-PACIFIC: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 92: ASIA-PACIFIC: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 93: CHINA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 94: CHINA: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 95: CHINA: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 96: CHINA: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 97: JAPAN: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 98: JAPAN: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 99: JAPAN: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 100: JAPAN: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 101: INDIA: BIOBANKING MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 102: INDIA: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 103: INDIA: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 104: INDIA: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 105: SOUTH KOREA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 106: SOUTH KOREA: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 107: SOUTH KOREA: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 108: SOUTH KOREA: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 109: AUSTRALIA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 110: AUSTRALIA: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 111: AUSTRALIA: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 112: AUSTRALIA: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 113: ROAPAC: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 114: ROAPAC: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 115: ROAPAC: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 116: ROA: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 117: ROW: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 118: ROW: BIOBANKING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2015-2022 (USD MILLION)
  • TABLE 119: ROW: BIOBANKING CONSUMABLES MARKET, BY CONSUMABLES TYPE, 2015-2022 (USD MILLION)
  • TABLE 120: ROW: BIOBANKING SERVICES MARKET, BY SERVICES TYPE, 2015-2022 (USD MILLION)
  • TABLE 121: ROW: BIOBANKING MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 122: ROW: BIOBANKING MARKET, BY STORAGE TYPE, 2015-2022 (USD MILLION)
  • TABLE 123: ROW: BIOBANKING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 3: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 4: BIOBANKING MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2017 VS. 2022 (USD BILLION)
  • FIGURE 8: BIOBANKING MARKET, BY SAMPLE TYPE, 2017 VS. 2022 (USD BILLION)
  • FIGURE 9: BIOBANKING MARKET, BY STORAGE TYPE, 2017 VS. 2022 (USD BILLION)
  • FIGURE 10: BIOBANKING MARKET, BY APPLICATION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 11: BIOBANKING MARKET, BY REGION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 12: INCREASING NUMBER OF GENOMICS RESEARCH ACTIVITIES AND THE NEED FOR COST-EFFICIENT DRUG DISCOVERY ARE DRIVING THE GROWTH OF THE BIOBANKING MARKET
  • FIGURE 13: NORTH AMERICA IS ESTIMATED TO COMMAND THE LARGEST MARKET SHARE IN 2017
  • FIGURE 14: EQUIPMENT SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 15: APAC TO REGISTER THE HIGHEST CAGR BETWEEN 2017 & 2022
  • FIGURE 16: BIOBANKING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: EQUIPMENT SEGMENT TO DOMINATE THE BIOBANKING MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: STORAGE EQUIPMENT SEGMENT TO DOMINATE THE BIOBANKING EQUIPMENT MARKET IN 2017-2022
  • FIGURE 19: BLOOD PRODUCTS SEGMENT TO DOMINATE THE BIOBANKING MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: MANUAL STORAGE SEGMENT WILL CONTINUE TO DOMINATE THE BIOBANKING MARKET IN 2022
  • FIGURE 21: REGENERATIVE MEDICINE TO DOMINATE THE BIOBANKING APPLICATIONS MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: ASIA-PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE BIOBANKING MARKET DURING THE FORECAST PERIOD
  • FIGURE 23: NORTH AMERICA: BIOBANKING MARKET SNAPSHOT
  • FIGURE 24: BIOBANKING EQUIPMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. MARKET IN 2017
  • FIGURE 25: EUROPE: MARKET SNAPSHOT
  • FIGURE 26: BLOOD PRODUCTS SEGMENT TO REGISTER THE FASTEST GROWTH IN THE GERMAN BIOBANKING MARKET FOR SAMPLE TYPE DURING THE FORECAST PERIOD
  • FIGURE 27: ASIA-PACIFIC: BIOBANKING MARKET SNAPSHOT
  • FIGURE 28: ROW: BIOBANKING MARKET SNAPSHOT
  • FIGURE 29: BIOBANKING MARKET: MARKET SHARE (2016)
  • FIGURE 30: BIOBANKING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2017
  • FIGURE 31: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 32: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016)
  • FIGURE 33: QIAGEN N.V.: COMPANY SNAPSHOT (2016)
  • FIGURE 34: MERCK KGAA: COMPANY SNAPSHOT (2016)
  • FIGURE 35: VWR CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 36: TECAN TRADING AG.: COMPANY SNAPSHOT (2016)
  • FIGURE 37: BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 38: CHART INDUSTRIES, INC.: COMPANY SNAPSHOT (2016)
Back to Top